- Home
- LENZ vs HEPS Comparison
LENZ vs HEPS Comparison
Compare LENZ & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- HEPS
- Stock Information
- Founded
- LENZ 2019
- HEPS 2000
- Country
- LENZ United States
- HEPS Turkey
- Employees
- LENZ N/A
- HEPS N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- HEPS Catalog/Specialty Distribution
- Sector
- LENZ Health Care
- HEPS Consumer Discretionary
- Exchange
- LENZ Nasdaq
- HEPS Nasdaq
- Market Cap
- LENZ 886.0M
- HEPS 909.5M
- IPO Year
- LENZ 2021
- HEPS 2021
- Fundamental
- Price
- LENZ $37.85
- HEPS $2.96
- Analyst Decision
- LENZ Strong Buy
- HEPS
- Analyst Count
- LENZ 4
- HEPS 0
- Target Price
- LENZ $49.75
- HEPS N/A
- AVG Volume (30 Days)
- LENZ 624.8K
- HEPS 617.2K
- Earning Date
- LENZ 07-30-2025
- HEPS 07-30-2025
- Dividend Yield
- LENZ N/A
- HEPS N/A
- EPS Growth
- LENZ N/A
- HEPS N/A
- EPS
- LENZ N/A
- HEPS N/A
- Revenue
- LENZ $5,000,000.00
- HEPS $1,477,672,859.00
- Revenue This Year
- LENZ N/A
- HEPS $33.20
- Revenue Next Year
- LENZ $556.26
- HEPS $25.66
- P/E Ratio
- LENZ N/A
- HEPS N/A
- Revenue Growth
- LENZ N/A
- HEPS 49.45
- 52 Week Low
- LENZ $16.54
- HEPS $2.11
- 52 Week High
- LENZ $41.70
- HEPS $4.05
- Technical
- Relative Strength Index (RSI)
- LENZ 60.20
- HEPS 62.94
- Support Level
- LENZ $34.88
- HEPS $2.61
- Resistance Level
- LENZ $40.95
- HEPS $3.09
- Average True Range (ATR)
- LENZ 2.90
- HEPS 0.14
- MACD
- LENZ 0.84
- HEPS 0.04
- Stochastic Oscillator
- LENZ 72.32
- HEPS 80.60
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.